Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance. This is page number 16.
Order by Relevance | Date
Total 1783 results found since Jan 2013.
Case Report: Various Clinical Manifestations Caused by Varicella-Zoster Virus in a Family
Front Pediatr. 2022 Jun 6;10:876250. doi: 10.3389/fped.2022.876250. eCollection 2022.ABSTRACTA family cluster of varicella-zoster virus (VZV) infections was reported. Four family members (two children and their parents) continuously develop varicella after the grandmother's herpes zoster. The unvaccinated 16-month-old infant and his mother developed primary varicella with atypical clinical presentation; however, his 28-year-old father presented with a typical generalized vesicular rash. His vaccinated 4-year-old sister was clinically mild, which could be defined as a breakthrough varicella case. They infected the same viru...
Source: Herpes - June 23, 2022 Category: Infectious Diseases Authors: Qinghong Meng Bingsong Wang Xianlai Zhang Zhen Li Wenjie Wang Kaihu Yao Source Type: research
Reactivation of Herpes Zoster Virus After COVID-19 Vaccination: Is There Any Association?
We report 10 incidences of herpes zoster reactivation within 7-21 days of getting the COVID-19 vaccination. Transient immunomodulation following vaccination, similar to that seen in COVID-19 illness, could be one explanation for this reactivation. These cases highlight the significance of continuing to examine vaccine safety during the COVID-19 pandemic's ongoing mass vaccination campaign. We also underline the importance of peripheral health professionals in the management and reporting of any vaccination-associated adverse event.PMID:35746994 | PMC:PMC9209775 | DOI:10.7759/cureus.25195
Source: Herpes - June 24, 2022 Category: Infectious Diseases Authors: Surbhi Agrawal Kapila Verma Ishan Verma Jagriti Gandhi Source Type: research
Case Report: Various Clinical Manifestations Caused by Varicella-Zoster Virus in a Family
Front Pediatr. 2022 Jun 6;10:876250. doi: 10.3389/fped.2022.876250. eCollection 2022.ABSTRACTA family cluster of varicella-zoster virus (VZV) infections was reported. Four family members (two children and their parents) continuously develop varicella after the grandmother's herpes zoster. The unvaccinated 16-month-old infant and his mother developed primary varicella with atypical clinical presentation; however, his 28-year-old father presented with a typical generalized vesicular rash. His vaccinated 4-year-old sister was clinically mild, which could be defined as a breakthrough varicella case. They infected the same viru...
Source: Herpes - June 23, 2022 Category: Infectious Diseases Authors: Qinghong Meng Bingsong Wang Xianlai Zhang Zhen Li Wenjie Wang Kaihu Yao Source Type: research
Reactivation of Herpes Zoster Virus After COVID-19 Vaccination: Is There Any Association?
We report 10 incidences of herpes zoster reactivation within 7-21 days of getting the COVID-19 vaccination. Transient immunomodulation following vaccination, similar to that seen in COVID-19 illness, could be one explanation for this reactivation. These cases highlight the significance of continuing to examine vaccine safety during the COVID-19 pandemic's ongoing mass vaccination campaign. We also underline the importance of peripheral health professionals in the management and reporting of any vaccination-associated adverse event.PMID:35746994 | PMC:PMC9209775 | DOI:10.7759/cureus.25195
Source: Herpes - June 24, 2022 Category: Infectious Diseases Authors: Surbhi Agrawal Kapila Verma Ishan Verma Jagriti Gandhi Source Type: research
Survey of Physician Practices, Attitudes, and Knowledge Regarding Recombinant Zoster Vaccine
CONCLUSION: Most primary care physicians welcome updated ACIP RZV recommendations for immunocompromised adults. Knowledge gaps, communication issues, and financial barriers need to be addressed to optimize vaccination delivery.PMID:35794307 | PMC:PMC9261227 | DOI:10.1007/s11606-022-07721-z
Source: Topics in HIV Medicine - July 6, 2022 Category: Infectious Diseases Authors: Laura P Hurley Sean T O'Leary Kathleen Dooling Tara C Anderson Lori A Crane Jessica R Cataldi Michaela Brtnikova Brenda L Beaty Carol Gorman Angela Guo Megan C Lindley Allison Kempe Source Type: research
Zoster sine herpete following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient
IDCases. 2022 Jul 13;29:e01563. doi: 10.1016/j.idcr.2022.e01563. eCollection 2022.ABSTRACTAs a result of the COVID-19 pandemic, mRNA vaccination has become widespread. Recently, it has been suggested that instances of herpes zoster increase following mRNA COVID-19 vaccination. Herein, we describe the first case of zoster sine herpete (ZSH) after mRNA vaccination for COVID-19. A 60-year-old Japanese immunocompetent man presented with fever, fatigue, headache, cervical pain, and lumbar pain, which developed after receiving a second dose of BNT162b2 mRNA COVID-19 vaccination. Whereas most symptoms improved with symptomatic tr...
Source: Herpes - July 20, 2022 Category: Infectious Diseases Authors: Ryutaro Tanizaki Yayoi Miyamatsu Source Type: research
Cost-effectiveness of herpes zoster vaccines in the U.S.: A systematic review
Prev Med Rep. 2022 Jul 22;29:101923. doi: 10.1016/j.pmedr.2022.101923. eCollection 2022 Oct.ABSTRACTThe purpose of this study was to conduct a systematic review to evaluate the cost-effectiveness evidence of herpes zoster vaccines in the U.S. A systematic literature review was undertaken for U.S. studies focused on the cost-effectiveness of herpes zoster vaccines. Eligibility criteria included studies that evaluated the cost-effectiveness of the recombinant zoster vaccine (RZV) and zoster vaccine live (ZVL) and were published between 2015 and 2021. Article titles and abstracts were reviewed to identify relevant publication...
Source: Herpes - July 28, 2022 Category: Infectious Diseases Authors: Neil R Meredith Edward P Armstrong Source Type: research
